跳至主要内容
临床试验/NCT06549920
NCT06549920进行中(未招募)不适用

Danish Breast Cancer Group Internal Mammary Node Study

Danish Breast Cancer Cooperative Group0 个研究点目标入组 7,630 人开始时间: 2003年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
7,630
主要终点
Overall survival

研究概览

简要总结

The DBCG IMN study is a nationwide prospective population-based cohort study allocating node-positive breast cancer patients with right-sided tumors to internal mammary node irradiation (IMNI) and patients with left-sided tumors to no IMNI.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with macrometastatic node-positive breast cancer treated with loco-regional radiotherapy.

排除标准

  • Prior malignancies, bilateral breast cancer, neoadjuvant systemic therapy, recurrence before radiotherapy, and non-standard radiotherapy.

结局指标

主要结局

Overall survival

时间窗: 15-years.

Censored at end of study or by emigration.

次要结局

  • Breast cancer mortality(15-years.)
  • Distant recurrences(15-years.)

研究者

发起方
Danish Breast Cancer Cooperative Group
申办方类型
Other
责任方
Principal Investigator
主要研究者

Birgitte Offersen

Professor

Danish Breast Cancer Cooperative Group

相似试验